Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    This updates the displayed ClinicalTrials.gov site revision/version label from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T05:14:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added collaborator Ono Pharmaceutical Co., Ltd.; removed Ono Pharmaceutical Co. Ltd. Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:32:56.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:01:56.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:40.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the Notice about lapse in government funding and the previous Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T11:48:11.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government funding lapse notice affecting site operations and a Lancet Oncology CheckMate 025 reference; removed the Lancet Oncology Erratum citation for that article (revision: v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-04T10:30:04.000Z thumbnail image

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.